Status:
UNKNOWN
Radiological Evaluation of Sarcopenia in Patient Received Chemotherapy
Lead Sponsor:
Assiut University
Conditions:
Sarcopenia
Eligibility:
All Genders
18-65 years
Brief Summary
Radiological evaluation of sarcopenia in patients receiving chemotherapy
Detailed Description
Evaluation of muscle mass by using sonoelastography and computed tomography
Eligibility Criteria
Inclusion
- all cancer patients receiving chemotherapy referred to radiodiagnosis department for routine examination Patients must be between 18 and
Exclusion
- Previous or current history of any musculoskeletal or neurological disorder including strokes.
- Systemic atrophy affecting CNS ( Huntington disease ,hereditary ataxia ,spinal muscular disorder and related syndromes ,post polio syndrome )
- Central nervous system demyelinating disease ( Multiple sclerosis , acute disseminated demyelinated syndromes..
- Corticosteroids undertaken currently or for the past 3 years with doses \>5mg/day.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06166134
Start Date
January 1 2024
End Date
April 1 2025
Last Update
December 12 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.